None listed
Conditions
Brief summary
Of interest to this study is the role specific species and strains of probiotics could play in reducing the incidence and/or severity of respiratory and gastrointestinal symptoms infections in elite team sport athletes who travel frequently. The impact of endurance exercise on immune function is well established with a body of research to support that in a significant number of athletes, the physical and mental stress endured by elite athletes can result in an increased susceptibility to gastrointestinal and respiratory infections. Furthermore, a number of trials have investigated the efficacy of supplementing with specific Lactobacilli and Bifidobacteria in reducing respiratory infections.
Interventions
A proprietary blend of probiotic bacteria capsules (twice daily with food) and yeast capsules (twice daily with food) or placebo will be given to elite team athletes for 7 months. At the end of the trial all remaining capsules will be returned and counted as a means of measuring compliance. In addition, the head trainer will provide reminders regarding taking the trial medicine to improve compliance The details of the probiotic and yeasts are commercial and in confidence and listed privately with the ANZCTR
Sponsors
Study design
Eligibility
Inclusion criteria
Elite team athletes that are member of the Australian Rugby Union who travel for intensive competition periods. We do not want to disclose to the public or competitors which ARU team is participating in this trial.
Exclusion criteria
Any player not in good medical health or with any diagnosed medical condition of the immune or gastrointestinal system.